Pay in 4 interest-free payments of $5.00 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
GLP-1 Boom Sparks Potential 'Bubble Effect,' Shrinking Competition In Big Pharma, Warns Deloitte: 'The Question Is...' Big pharma is currently facing a potential "bubble effect" due to the surging demand for weight loss and diabetes drugs, as revealed in a report by Deloitte released on Monday
The difference is in how they structure their pharmacy relationships and medical documentation
A more stable, physiologically buffered glucagon solution is additionally attractive for potential use in a bi-hormonal pump for treatment of type 1 diabetes
2 Materials and methods 2.1 Data acquisition and processing Figure 1 depicts a comprehensive flowchart of the research procedure
